Search Results - "Sriram, Dharmarajan"

Refine Results
  1. 1

    Inhibition of protein kinase R protects against palmitic acid–induced inflammation, oxidative stress, and apoptosis through the JNK/NF‐kB/NLRP3 pathway in cultured H9C2 cardiomyocytes by Mangali, Sureshbabu, Bhat, Audesh, Udumula, Mary Priyanka, Dhar, Indu, Sriram, Dharmarajan, Dhar, Arti

    Published in Journal of cellular biochemistry (01-03-2019)
    “…Background and Purpose Double‐stranded RNA‐dependent protein kinase (PKR) is a critical regulator of apoptosis, oxidative stress, and inflammation under…”
    Get full text
    Journal Article
  2. 2

    Ultrasonication-ionic liquid synergy for the synthesis of new potent anti-tuberculosis 1,2,4-triazol-1-yl-pyrazole based spirooxindolopyrrolizidines by Pogaku, Vinay, Krishna, Vagolu Siva, Sriram, Dharmarajan, Rangan, Krishnan, Basavoju, Srinivas

    Published in Bioorganic & medicinal chemistry letters (01-07-2019)
    “…[Display omitted] •New potent anti-TB spirooxindolopyrrolizidines were designed & synthesized by green methodology.•High yields of the products in less…”
    Get full text
    Journal Article
  3. 3

    Synthesis of novel morpholine, thiomorpholine and N-substituted piperazine coupled 2-(thiophen-2-yl)dihydroquinolines as potent inhibitors of Mycobacterium tuberculosis by Marvadi, Sandeep Kumar, Krishna, Vagolu Siva, Sriram, Dharmarajan, Kantevari, Srinivas

    Published in European journal of medicinal chemistry (15-02-2019)
    “…A series of novel morpholine, thiomorpholine and N-substituted piperazine coupled 2-(thiophen-2-yl)dihydroquinolines 7a–p was designed and synthesized from…”
    Get full text
    Journal Article
  4. 4

    Betulinic acid and its derivatives: a review on their biological properties by Yogeeswari, Perumal, Sriram, Dharmarajan

    Published in Current medicinal chemistry (01-01-2005)
    “…Betulinic acid is a naturally occurring pentacyclic triterpenoid and has been shown to exhibit a variety of biological activities including inhibition of human…”
    Get more information
    Journal Article
  5. 5

    Pyrazole–coumarin and pyrazole–quinoline chalcones as potential antitubercular agents by Kumar, Gautam, Siva Krishna, Vagolu, Sriram, Dharmarajan, Jachak, Sanjay M.

    Published in Archiv der Pharmazie (Weinheim) (01-08-2020)
    “…Pyrazole, coumarin, and quinoline are medicinally important moieties. In this study, two series of novel pyrazole–coumarin chalcones and pyrazole–quinoline…”
    Get full text
    Journal Article
  6. 6

    Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents by Marvadi, Sandeep Kumar, Krishna, Vagolu Siva, Sriram, Dharmarajan, Kantevari, Srinivas

    Published in Bioorganic & medicinal chemistry letters (15-02-2019)
    “…[Display omitted] A series of novel substituted 1,2,3-triazolyldihydroquinolines 6a–o was designed and synthesized from 2-acetylthiophene in five-step reaction…”
    Get full text
    Journal Article
  7. 7

    Discovery of Antimycobacterial Spiro-piperidin-4-ones: An Atom Economic, Stereoselective Synthesis, and Biological Intervention by Kumar, Raju Ranjith, Perumal, Subbu, Senthilkumar, Palaniappan, Yogeeswari, Perumal, Sriram, Dharmarajan

    Published in Journal of medicinal chemistry (25-09-2008)
    “…An atom economic and stereoselective synthesis of several spiro-piperidin-4-ones through 1,3-dipolar cycloaddition of azomethine ylides generated in situ from…”
    Get full text
    Journal Article
  8. 8

    Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors by Samala, Ganesh, Devi, Parthiban Brindha, Saxena, Shalini, Meda, Nikhila, Yogeeswari, Perumal, Sriram, Dharmarajan

    Published in Bioorganic & medicinal chemistry (15-03-2016)
    “…Compound 5bc emerged as potent compound active against MTB PS with IC50 of 0.53±0.13μM, MIC of 3.53μM, 2.1log reduction against nutrient starved MTB. It also…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads by Tanwar, Babita, Kumar, Asim, Yogeeswari, Perumal, Sriram, Dharmarajan, Chakraborti, Asit K.

    Published in Bioorganic & medicinal chemistry letters (15-12-2016)
    “…[Display omitted] Two series of quinoline-based compounds were designed, synthesised and evaluated for anti-tubercular activity against Mycobacterium…”
    Get full text
    Journal Article
  11. 11

    Design, Synthesis, and Evaluation of Thiol-Activated Sources of Sulfur Dioxide (SO2) as Antimycobacterial Agents by Malwal, Satish R, Sriram, Dharmarajan, Yogeeswari, Perumal, Konkimalla, V. Badireenath, Chakrapani, Harinath

    Published in Journal of medicinal chemistry (12-01-2012)
    “…Here, 2,4-dinitrophenylsulfonamides with tunable cysteine-activated SO2 release profiles with half-lives of SO2 release varying from 2 to 63 min are reported…”
    Get full text
    Journal Article
  12. 12

    Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads by Krishna, Vagolu Siva, Zheng, Shan, Rekha, Estharla Madhu, Guddat, Luke W., Sriram, Dharmarajan

    Published in Journal of computer-aided molecular design (01-03-2019)
    “…Tuberculosis (TB) remains a major threat to human health. This due to the fact that current drug treatments are less than optimal and the increasing occurrence…”
    Get full text
    Journal Article
  13. 13

    Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship by Dhameliya, Tejas M., Tiwari, Rishu, Banerjee, Arkaprabha, Pancholia, Sahaj, Sriram, Dharmarajan, Panda, Dulal, Chakraborti, Asit K.

    Published in European journal of medicinal chemistry (15-07-2018)
    “…Tuberculosis is the second leading cause of deaths worldwide. The inadequacy of existing drugs to treat TB due to developed resistance and TB-HIV synergism…”
    Get full text
    Journal Article
  14. 14

    Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors by Malapati, Prasanthi, Krishna, Vagolu Siva, Nallangi, Radhika, Srilakshmi, Rudraraju Reshma, Sriram, Dharmarajan

    Published in European journal of medicinal chemistry (10-02-2018)
    “…In the present study, we attempted to develop novel class of Mycobacterium tuberculosis (Mtb) inhibitors by exploring the pharmaceutically underexploited…”
    Get full text
    Journal Article
  15. 15

    Divergent downstream biosynthetic pathways are supported by L-cysteine synthases of Mycobacterium tuberculosis by Khan, Mehak Zahoor, Hunt, Debbie M, Singha, Biplab, Kapoor, Yogita, Singh, Nitesh Kumar, Prasad, D V Sai, Dharmarajan, Sriram, Sowpati, Divya Tej, de Carvalho, Luiz Pedro S, Nandicoori, Vinay Kumar

    Published in eLife (29-08-2024)
    “…'s ( ) autarkic lifestyle within the host involves rewiring its transcriptional networks to combat host-induced stresses. With the help of RNA sequencing…”
    Get full text
    Journal Article
  16. 16

    New N -phenylacetamide-incorporated 1,2,3-triazoles: [Et 3 NH][OAc]-mediated efficient synthesis and biological evaluation by Akolkar, Satish V, Nagargoje, Amol A, Krishna, Vagolu S, Sriram, Dharmarajan, Sangshetti, Jaiprakash N, Damale, Manoj, Shingate, Bapurao B

    Published in RSC advances (18-07-2019)
    “…A facile, highly efficient, and greener method for the synthesis of new 1,4-disubstituted-1,2,3-triazoles was conducted using [Et NH][OAc] as a medium by the…”
    Get full text
    Journal Article
  17. 17

    Discovery of potent antimycobacterial agents targeting lumazine synthase (RibH) of Mycobacterium tuberculosis by Singh, Monica, Dhanwal, Anannya, Verma, Arpita, Augustin, Linus, Kumari, Niti, Chakraborti, Soumyananda, Agarwal, Nisheeth, Sriram, Dharmarajan, Dey, Ruchi Jain

    Published in Scientific reports (28-05-2024)
    “…Tuberculosis (TB) continues to be a global health crisis, necessitating urgent interventions to address drug resistance and improve treatment efficacy. In this…”
    Get full text
    Journal Article
  18. 18

    Indole-fused spirochromenes as potential anti-tubercular agents: design, synthesis and in vitro evaluation by Dogamanti, Ashok, Chiranjeevi, Pamula, Aamate, Vikas Kumar, Vagolu, Siva Krishna, Sriram, Dharmarajan, Balasubramanian, Sridhar, Sarasija, Madderla

    Published in Molecular diversity (01-11-2021)
    “…As part of an ongoing effort to develop new anti-tubercular agents, a series of novel indole-fused spirochromene hybrids ( 7a–l ) were efficiently synthesized…”
    Get full text
    Journal Article
  19. 19

    A facile synthesis and antimycobacterial evaluation of novel spiro-pyrido-pyrrolizines and pyrrolidines by Ranjith Kumar, Raju, Perumal, Subbu, Senthilkumar, Palaniappan, Yogeeswari, Perumal, Sriram, Dharmarajan

    Published in European journal of medicinal chemistry (01-09-2009)
    “…An efficient synthesis of 1-methyl-3-[( E)-arylmethylidene]tetrahydro-4(1 H)-pyridinones was achieved by the reaction of 1-methyl-4-piperidone and aromatic…”
    Get full text
    Journal Article
  20. 20

    1,2,3-Triazole-fused spirochromenes as potential anti-tubercular agents: synthesis and biological evaluation by Ashok, Dongamanti, Chiranjeevi, Pamula, Kumar, Aamate Vikas, Sarasija, Madderla, Krishna, Vagolu Siva, Sriram, Dharmarajan, Balasubramanian, Sridhar

    Published in RSC advances (01-01-2018)
    “…A facile and convenient approach has been designed for the synthesis of novel prototypes that possess the advantage of the two pharmacophores of chromene and…”
    Get full text
    Journal Article